Home › Companies › UTAH MEDICAL PRODUCTS INC. › 2023-2024

UTAH MEDICAL PRODUCTS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated 02 October 2026.

6Reported items
155Asset managers
808Fund votes
2024-05-03Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore UTAH MEDICAL PRODUCTS INC. in the interactive database Compare manager voting policies

How asset managers voted at the UTAH MEDICAL PRODUCTS INC. 2023-2024 meeting

Each item below shows how the 155 asset managers that disclosed a UTAH MEDICAL PRODUCTS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of UTAH MEDICAL PRODUCTS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, by advisory vote, the Company's executive compensation program;

SECTION 14A SAY-ON-PAY VOTES

Combines 8 wordings of this item as funds reported it.

99.4% fund support · no official result

FOR 99.4%

The 125 asset managers below cast 99.4% of the shares they voted on this item FOR (2,559,226 for, 14,762 against).

FOR: 2,559,226 (99.4%)AGAINST: 14,762 (0.6%)UNKNOWN: 60 (0.0%)

Largest asset managers voting on “To approve, by advisory vote, the Company's executive compensation program;” at UTAH MEDICAL PRODUCTS INC., 2023-2024
Asset manager	For	Against	Vote
Fidelity	771,912	0	For
T. Rowe Price	301,232	0	For
Renaissance	188,653	0	For
Vanguard	172,026	0	For
BlackRock	167,097	0	For
Dimensional	159,627	0	For
JPMorgan	112,363	0	For
GEODE CAPITAL MANAGEMENT, LLC	73,254	0	For
State Street	69,836	0	For
Ranger Investment Management, L.P.	51,017	0	For
FRANKLIN MUTUAL ADVISERS LLC	41,696	0	For
FRANKLIN VALUE INVESTORS TRUST	41,696	0	For
Clean Yield Group	31,194	0	For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	31,020	0	For
Citadel	26,923	0	For
WisdomTree	21,769	0	For
Two Sigma	21,113	0	For
ISTHMUS PARTNERS, LLC	20,389	0	For
Goldman Sachs	17,024	0	For
Royce	15,800	0	For
American Century	0	14,124	Against
MELLON INVESTMENTS Corp	13,421	0	For
Northern Trust	12,121	0	For
Natixis	11,704	0	For
Nuveen	11,229	0	For

Showing the 25 largest of 125 asset managers. See all 125 in the interactive database.

2. To elect two directors of the Company to serve a three year term and until their successor is elected and qualified: Kevin L. Cornwell

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

99.6% fund support · no official result

FOR 46.6%ABSTAIN 53.2%

The 58 asset managers below cast 99.6% of the shares they voted on this item FOR (606,740 for, 2,080 against).

FOR: 606,740 (46.6%)AGAINST: 2,080 (0.2%)ABSTAIN: 691,800 (53.2%)UNKNOWN: 60 (0.0%)

Largest asset managers voting on “To elect two directors of the Company to serve a three year term and until their successor is elected and qual” at UTAH MEDICAL PRODUCTS INC., 2023-2024
Asset manager	For	Abstain	Vote
Fidelity	69,332	319,145	Abstain
Vanguard	165,572	0	For
Dimensional	0	144,497	Abstain
JPMorgan	111,018	0	For
T. Rowe Price	0	110,632	Abstain
BlackRock	105,217	0	For
FRANKLIN VALUE INVESTORS TRUST	0	41,696	Abstain
Russell Investments	26,730	0	For
WisdomTree	0	21,769	Abstain
Royce	15,114	0	For
Charles Schwab	14,172	0	For
CLEARWATER INVESTMENT TRUST	12,056	0	For
TIAA	11,179	0	For
Advisors' Inner Circle Fund III	0	10,948	Abstain
Equitable	6,018	4,800	For
SEI	9,952	0	For
HOTCHKIS & WILEY FUNDS /DE/	0	9,900	Abstain
Goldman Sachs	9,271	0	For
BRANDES INVESTMENT TRUST	8,425	0	For
Principal	0	7,988	Abstain
QUANTITATIVE MASTER SERIES LLC	5,891	0	For
Lincoln Financial	2,915	2,100	For
Nationwide	3,854	936	For
American Century	0	4,726	Abstain
Columbia Threadneedle	4,600	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

3. To elect two directors of the Company to serve a three year term and until their successor is elected and qualified: Paul O. Richins

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

99.4% fund support · no official result

FOR 30%ABSTAIN 70%

The 58 asset managers below cast 99.4% of the shares they voted on this item FOR (392,876 for, 2,080 against).

FOR: 392,876 (30.2%)AGAINST: 2,080 (0.2%)ABSTAIN: 905,664 (69.6%)UNKNOWN: 60 (0.0%)

Largest asset managers voting on “To elect two directors of the Company to serve a three year term and until their successor is elected and qual” at UTAH MEDICAL PRODUCTS INC., 2023-2024
Asset manager	For	Abstain	Vote
Fidelity	69,332	319,145	Abstain
Vanguard	165,572	0	For
Dimensional	0	144,497	Abstain
JPMorgan	111,018	0	For
T. Rowe Price	0	110,632	Abstain
BlackRock	0	105,217	Abstain
FRANKLIN VALUE INVESTORS TRUST	0	41,696	Abstain
Russell Investments	26,730	0	For
WisdomTree	0	21,769	Abstain
Royce	15,114	0	For
Charles Schwab	0	14,172	Abstain
CLEARWATER INVESTMENT TRUST	0	12,056	Abstain
TIAA	0	11,179	Abstain
Advisors' Inner Circle Fund III	0	10,948	Abstain
Equitable	0	10,818	Abstain
SEI	0	9,952	Abstain
HOTCHKIS & WILEY FUNDS /DE/	0	9,900	Abstain
Goldman Sachs	0	9,271	Abstain
BRANDES INVESTMENT TRUST	0	8,425	Abstain
Principal	0	7,988	Abstain
QUANTITATIVE MASTER SERIES LLC	0	5,891	Abstain
Lincoln Financial	0	5,015	Abstain
Nationwide	0	4,790	Abstain
American Century	0	4,726	Abstain
Columbia Threadneedle	0	4,600	Abstain

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

4. To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year ending December 31, 2024;

AUDIT-RELATED

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 58 asset managers below cast 100% of the shares they voted on this item FOR (1,300,620 for, 0 against).

FOR: 1,300,620 (100.0%)UNKNOWN: 60 (0.0%)

Largest asset managers voting on “To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year e” at UTAH MEDICAL PRODUCTS INC., 2023-2024
Asset manager	For	Vote
Fidelity	388,477	For
Vanguard	165,572	For
Dimensional	144,497	For
JPMorgan	111,018	For
T. Rowe Price	110,632	For
BlackRock	105,217	For
FRANKLIN VALUE INVESTORS TRUST	41,696	For
Russell Investments	26,730	For
WisdomTree	21,769	For
Royce	15,114	For
Charles Schwab	14,172	For
CLEARWATER INVESTMENT TRUST	12,056	For
TIAA	11,179	For
Advisors' Inner Circle Fund III	10,948	For
Equitable	10,818	For
SEI	9,952	For
HOTCHKIS & WILEY FUNDS /DE/	9,900	For
Goldman Sachs	9,271	For
BRANDES INVESTMENT TRUST	8,425	For
Principal	7,988	For
QUANTITATIVE MASTER SERIES LLC	5,891	For
Lincoln Financial	5,015	For
Nationwide	4,790	For
American Century	4,726	For
Columbia Threadneedle	4,600	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

5. To hold an advisory vote on the Company s executive compensation program.

SECTION 14A SAY-ON-PAY VOTES

91% fund support · no official result

FOR 90%9%

The 26 asset managers below cast 91% of the shares they voted on this item FOR (242,193 for, 25,101 against).

FOR: 242,193 (90.5%)AGAINST: 25,101 (9.4%)NOT VOTED: 454 (0.2%)

Largest asset managers voting on “To hold an advisory vote on the Company s executive compensation program.” at UTAH MEDICAL PRODUCTS INC., 2023-2024
Asset manager	For	Against	Vote
RICE HALL JAMES & ASSOCIATES, LLC	61,611	0	For
BRANDES INVESTMENT PARTNERS, LP	54,597	0	For
Russell Investments	34,900	0	For
Charles Schwab	28,344	0	For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	0	24,186	Against
SEI	19,904	0	For
CLEARWATER INVESTMENT TRUST	12,056	0	For
LSV ASSET MANAGEMENT	7,647	915	For
BRANDES INVESTMENT TRUST	8,425	0	For
ADVISORS' INNER CIRCLE FUND	2,729	0	For
Riverwater Partners LLC	2,330	0	For
STATE OF MICHIGAN RETIREMENT SYSTEM	2,311	0	For
Global X	1,629	0	For
NEW YORK STATE COMMON RETIREMENT FUND	1,429	0	For
Man Group plc	950	0	For
MARSHALL WACE, LLP	751	0	For
BANK OF AMERICA NA	548	0	For
NEW COVENANT FUNDS	515	0	For
Prudential/PGIM	354	0	For
OREGON PUBLIC EMPLOYEES RETIREMENT FUND	306	0	For
LOS ANGELES CAPITAL MANAGEMENT LLC	293	0	For
MACKENZIE FINANCIAL CORP	237	0	For
Neuberger Berman	192	0	For
Nationwide	105	0	For
YOUSIF CAPITAL MANAGEMENT, LLC	30	0	For

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (61,777 for, 0 against).

FOR: 61,777 (100.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at UTAH MEDICAL PRODUCTS INC., 2023-2024
Asset manager	For	Vote
JPMorgan	61,397	For
ALGERT GLOBAL LLC	260	For
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	120	For

Largest UTAH MEDICAL PRODUCTS INC. shareholders voting in 2023-2024

Ranked by the number of UTAH MEDICAL PRODUCTS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 3,589,014 shares outstanding at the time of that meeting.

Top UTAH MEDICAL PRODUCTS INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Fidelity	21.51%
2	T. Rowe Price	8.39%
3	Renaissance	5.26%
4	Vanguard	4.79%
5	BlackRock	4.66%
6	Dimensional	4.45%
7	JPMorgan	3.13%
8	GEODE CAPITAL MANAGEMENT, LLC	2.04%
9	State Street	1.95%
10	Ranger Investment Management, L.P.	1.42%

Reported UTAH MEDICAL PRODUCTS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

UTAH MEDICAL PRODUCTS INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Renaissance Technologies	6.48%	13F
BlackRock	5.01%	13F
Vanguard Group	4.89%	13F
Dimensional Fund Advisors	4.50%	13F
State Street	2.25%	13F
Geode Capital	2.05%	13F
Morgan Stanley	1.60%	13F
Millennium Management	1.41%	13F
BNY Mellon	1.34%	13F
Franklin Templeton	1.17%	13F

Percentages above are of 3,589,014 shares outstanding, as reported by UTAH MEDICAL PRODUCTS INC. on its Form 10-K dated 2024-03-25 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UTAH MEDICAL PRODUCTS INC.’s 10-K dated 2024-03-25. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At UTAH MEDICAL PRODUCTS INC.'s shareholder meeting held 2024-05-03, in the 2023-2024 proxy season, 155 asset managers reported how they voted in their SEC Form N-PX filings, covering 808 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, by advisory vote, the Company's executive compensation program; — the reporting funds cast 99.4% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

UTAH MEDICAL PRODUCTS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.